Skip to main content
Clinical Trials/NCT02589405
NCT02589405
Completed
Phase 4

Benzaknen® 5% Gel in Combination With Dermotivin® Soft Liquid Soap and Non-comedogenic Cetaphil® Dermacontrol Moisturizer SPF30 in the Treatment of Mild-to-moderate Acne Vulgaris

Galderma R&D1 site in 1 country50 target enrollmentAugust 2015

Overview

Phase
Phase 4
Intervention
Benzoyl Peroxide
Conditions
Acne Vulgaris
Sponsor
Galderma R&D
Enrollment
50
Locations
1
Primary Endpoint
Number of Participants Satisfied and Very Satisfied With Regimen
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to evaluate a complete acne regimen consisting of a medication (Benzaknen® 5% Gel), and 2 cosmetic products Dermotivin® Soft Liquid soap and Cetaphil® Dermacontrol Moisturizer SPF30 in patients with acne.

Detailed Description

The main objective of this study is to evaluate subject satisfaction with the treatment regimen comprising Benzaknen® 5% Gel in association with 2 cosmetic products including a foam soap, Dermotivin® Soft Liquid soap, and a non comedogenic moisturizer, Cetaphil® Dermacontrol Moisturizer SPF30, in patients with mild to moderate acne, after 12 weeks of treatment.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
January 2016
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female subject of any ethnic background of 12 years or older.
  • Subject with mild or moderate facial acne vulgaris defined as an Investigator Global Assessment (IGA) score at 2 or 3 on a 0-4 scale.
  • Subject with any skin phototype according to T.B. Fitzpatrick skin phototype definitions.

Exclusion Criteria

  • Subject with severe acne (IGA\>3) with nodules, cysts, scars or extra-facial lesions,
  • Female subject who is pregnant, lactating or planning a pregnancy during the study,
  • Subject susceptible to take a corticosteroid treatment during the study except inhaled or topic when needed to treat a condition outside the face,

Arms & Interventions

Benzaknen treatment regimen

Benzac® 5% Gel (once daily) + Dermotivin® Soft Liquid soap (twice daily) + Cetaphil® Dermacontrol Moisturizer SPF30 (once daily)

Intervention: Benzoyl Peroxide

Benzaknen treatment regimen

Benzac® 5% Gel (once daily) + Dermotivin® Soft Liquid soap (twice daily) + Cetaphil® Dermacontrol Moisturizer SPF30 (once daily)

Intervention: Dermotivin® Soft Liquid cleanser

Benzaknen treatment regimen

Benzac® 5% Gel (once daily) + Dermotivin® Soft Liquid soap (twice daily) + Cetaphil® Dermacontrol Moisturizer SPF30 (once daily)

Intervention: Cetaphil® Dermacontrol Moisturizer SPF30

Outcomes

Primary Outcomes

Number of Participants Satisfied and Very Satisfied With Regimen

Time Frame: 12 weeks

Number of subjects satisfied and very satisfied with the three-part treatment regimen

Study Sites (1)

Loading locations...

Similar Trials